# Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma

> **NCT06124976** · PHASE2,PHASE3 · RECRUITING · sponsor: **University of British Columbia** · enrollment: 70 (estimated)

## Conditions studied

- Urothelial Carcinoma of the Renal Pelvis and Ureter
- Transitional Cell Cancer of the Renal Pelvis and Ureter

## Interventions

- **DRUG:** ST-02

## Key facts

- **NCT ID:** NCT06124976
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-19
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06124976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06124976, "Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06124976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*